You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds

    SBC: Nortis, Inc.            Topic: R

    Project Summary Genetic predispositions in the human population are associated with unpredictable pharmacokinetic (PK) and pharmacodynamics (PD), which result in the loss of treatment efficacy or increase risks of adverse drug reactions (ADRs). The FDA estimates that ADRs are the 4th leading cause of death in the US, and treatment costs related to ADRs exceed $136 billion annually. Drug-induced li ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. High-Throughput NMJ Assay for Botox Potency Screening

    SBC: CURI BIO, INC.            Topic: NCATS

    PROJECT SUMMARY The Botulinum Toxin Potency Assay using Tissue Chips program from FDA and NCATS highlights the need for novel engineered systems capable of reliably evaluating botulinum toxin (BoT) potency. Human induced pluripotent stem cell (iPSC)-derived motor neurons and muscle cells have been previously maintained in co- culture and shown to form functional synaptic contacts representing in v ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Sodium Dodecyl Sulfate Removal Interface to Enable Characterization of Fragment Impurities in Monoclonal Antibodies by Capillary Electrophoresis Sodium Dodecyl Sulfate Coupled to Mass Spectrometry

    SBC: GMJ TECHNOLOGIES, INC.            Topic: 400

    PROGRAM SUMMARYMonoclonal antibodies (mAbs) have become mainstream therapeutic proteins in the biopharmaceutical industry (biopharma), and the demand for efficient analytical tools for their characterization and quality control continues to increase. During manufacturing and storage, cleavage of mAb’s primary structure can occur due to different fragmentation induced mechanisms, and the resultin ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Chromosomal aberration detection in FFPE tissue using proximity ligation sequencing

    SBC: PHASE GENOMICS, INC.            Topic: NCI

    ABSTRACT The detection of chromosomal aberrations is a frontline diagnostic for the spectrum of blood neoplasms. Chromosomal aberrations, such as translocations, inversions, deletions and insertions, have been historically identified using cytogenetic methods or more recently through application of long read sequencing or optical mapping technologies. These methods have been less applicable in sol ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Evaluation of a Next Generation SchistoShield Vaccine

    SBC: PAI LIFE SCIENCES INC            Topic: NIAID

    ABSTRACT Schistosomiasis is a major parasitic disease which could impact one billion people with 252 million currently infected and 779 million at risk to acquire the infection in 74 countries. Current control strategies have relied on repeated treatments with the drug praziquantel alone – however, this strategy has proven inadequate due to minimal reduction of disease transmission, reinfection, ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  6. Biological validation of phage host-range identified by proximity guided metagenomics

    SBC: PHASE GENOMICS, INC.            Topic: NIAID

    Abstract Phages are viruses that infect bacteria and have the potential to be used as a clinical tool for treating infectious diseases and gut microbiome-related disorders. Understanding phage-host interactions can improve the ability to use phages as a treatment option, and potentially lead to the development of new therapies. However, current methods for studying these interactions are low-throu ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  7. An expanded 75-color panel of Pdots for spectral multiplexing

    SBC: LAMPROGEN INC            Topic: 400

    Project Summary Flow cytometry is widely used in basic and translational research and in clinical diagnostic assays. Spectral flow cytometry represents a revolutionary change in the approach to flow cytometry by using full spectral information from each fluorophore—by collecting the emission over the full spectrum and using multiple excitation sources for each fluorophore to obtain a spectral †...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Modulation of Protein S-nitrosylation Signaling as a Potential Therapeutic Breakthrough in Rheumatoid Arthritis

    SBC: GSNO THERAPEUTICS, INC.            Topic: NIAMS

    PROJECT SUMMARY Rheumatoid arthritis (RA) is a prevalent autoimmune disease of the joints that involves autoimmunity, B and T cell infiltration, mitochondrial dysfunction, ECM degradation, oxidative stress and inflammation, that ultimately lead to cartilage destruction and bone reabsorption. Oxidative stress is a hallmark of RA: reactive oxygen species (ROS) inflict direct damage via the oxidation ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Apto-Ankle: Passive, Compliant Ankle with Enhanced Energy Storage and Return in Gait

    SBC: ORTHOCARE INNOVATIONS LLC            Topic: NICHD

    PROJECT SUMMARY The Apto-Ankle project will create a novel low-cost, lightweight, unpowered passive compliant ankle that addresses the weaknesses of currently marketed hydraulic passive ankles by combining +/-10° of plantar and dorsiflexion with a gait dependent toe lock to provide energy storage and return, all without use of microprocessors or powered components. Appropriate for DMERC K-2 and K ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Simultaneous pharmacological profiling of oncogenic gene fusion proteins in cancer

    SBC: TALUS BIOSCIENCE INC            Topic: 393

    RESEARCH SUMMARY The human genome encodes more than 1,600 transcription factors (TFs), along with additional cofactors, chromatin regulators, and structural proteins that collectively execute the regulatory instructions encoded within the nuclear DNA. Dysfunctions of these proteins, collectively known as Gene Regulatory Proteins (GRPs), are known to drive multiple diseases such as cancer, inflamma ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government